α-Synuclein通过STAT1-依赖的Ulk1转录抑制来破坏微质自
Chong-Shuang Pei1,2, Xiao-Ou Hou1,2, Zhen-Yuan Ma2
1Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, China.
Journal of neuroinflammation
|October 27, 2024
概括
帕金森病 (PD) 涉及受损的微质自. 这项研究揭示了α-synuclein (α-Syn) 激活STAT1,抑制ULK1并破坏自. 准STAT1或ULK1可以治疗PD.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 质细胞的自功能障碍是帕金森病 (PD) 发病的一个关键因素.
- 已知α-synuclein (α-Syn) 破坏了微质细胞的自,但潜在的机制尚不清楚.
研究的目的:
- 为了阐明在帕金森病中微细胞自失调的机制.
- 研究信号转换器和转录1激活器 (STAT1) 在α-synuclein诱导的自功能障碍中的作用.
主要方法:
- 使用基于α-synuclein的帕金森病小鼠模型 (AAV介导的α-Syn输送和α-Syn预制纤维素注射).
- 通过使用qPCR,西部涂抹和免疫染来评估与自相关的基因表达 (例如,ULK1) 和蛋白质水平.
- 研究了STAT1在ULK1转录中的调节作用,通过光酶测定,敲击/过度表达研究和条件淘汰模型.
主要成果:
- 在PD模型中,微质ULK1转录和自开始减少.
- 由α-synuclein激活STAT1抑制ULK1转录,导致自失调.
- 在PD模型中,STAT1切除或ULK1激活 (BL-918) 减弱了神经炎症,多巴胺能神经元损失和运动缺陷.
结论:
- 通过通过STAT1-介导的ULK1.1抑制,确定了一种新的机制,其中α-synuclein会通过STAT1-介导的ULK1.1抑制微细胞自.
- 准STAT1或ULK1是帕金森病的潜在治疗策略.
相关概念视频
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:37The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:36Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K